MDT

97.6

-1.71%↓

148.9

+1.14%↑

VEEV

242.56

-0.54%↓

HQY

95.52

-1.95%↓

PHR.US

17.28

+1.23%↑

MDT

97.6

-1.71%↓

148.9

+1.14%↑

VEEV

242.56

-0.54%↓

HQY

95.52

-1.95%↓

PHR.US

17.28

+1.23%↑

MDT

97.6

-1.71%↓

148.9

+1.14%↑

VEEV

242.56

-0.54%↓

HQY

95.52

-1.95%↓

PHR.US

17.28

+1.23%↑

MDT

97.6

-1.71%↓

148.9

+1.14%↑

VEEV

242.56

-0.54%↓

HQY

95.52

-1.95%↓

PHR.US

17.28

+1.23%↑

MDT

97.6

-1.71%↓

148.9

+1.14%↑

VEEV

242.56

-0.54%↓

HQY

95.52

-1.95%↓

PHR.US

17.28

+1.23%↑

Home・Lista de Ações・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Abrir

SetorSaúde

38.07 1.52

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

36.79

Máximo

38.12

Indicadores-chave
By Trading Economics
Rendimento	11M 51M
Vendas	39M 239M
P/E Médio do Setor	11.593 87.826
EPS	1.08
Margem de lucro	21.242
Funcionários	268
EBITDA	14M 73M

Recomendações
By TipRanks
Recomendações	Comprar
Previsão para 12 meses	+16.72% upside

Dividendos
By Dow Jones
Próximos Ganhos	24 de fev. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	429M 2.1B
Abertura anterior	36.55
Fecho anterior	38.07

Sentimento de Notícias

By Acuity

34%

66%

111 / 372 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bullish Evidence

29.8 / N/A Suporte e Resistência

Harmony Biosciences Holdings Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

8 de jan. de 2026, 23:08 UTC

Aquisições, Fusões, Aquisições de Empresas

Rio Tinto, Glencore in Talks to Form World's Biggest Miner -- 3rd Update

8 de jan. de 2026, 21:39 UTC

Aquisições, Fusões, Aquisições de Empresas

Glencore, Rio Tinto Restart Merger Talks -- 2nd Update

8 de jan. de 2026, 20:54 UTC

Aquisições, Fusões, Aquisições de Empresas

Glencore, Rio Tinto Restart Merger Talks -- Update

8 de jan. de 2026, 20:44 UTC

Aquisições, Fusões, Aquisições de Empresas

Glencore, Rio Tinto Restart Merger Talks

8 de jan. de 2026, 17:05 UTC

Aquisições, Fusões, Aquisições de Empresas

Chinese Anta Sports Products Offers to Buy Pinault Family's Stake in Puma, Reuters Says, Citing Unnamed Sources

8 de jan. de 2026, 16:43 UTC

Grandes Movimentos do Mercado

Babcock & Wilcox Shares Rise on Siemens Deal for Data Center Project

8 de jan. de 2026, 23:44 UTC

Conversa de Mercado

Nikkei May Rise on Weaker Yen -- Market Talk

8 de jan. de 2026, 23:37 UTC

Conversa de Mercado

Gold Steady, Underpinned by Geopolitical Risks -- Market Talk

8 de jan. de 2026, 22:42 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

8 de jan. de 2026, 22:42 UTC

Conversa de Mercado

RBA Still Battling a Troubling Inflation Outlook, Says TD -- Market Talk

8 de jan. de 2026, 22:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Glencore, Rio Tinto Confirm Early Merger Talks -- Barrons.com

8 de jan. de 2026, 21:53 UTC

Ganhos

These Stocks Moved the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

8 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Auto & Transport Roundup: Market Talk

8 de jan. de 2026, 21:10 UTC

Aquisições, Fusões, Aquisições de Empresas

Rio Tinto Says Current Expectation That Any Deal Would Involve Buying Glencore Via Scheme of Arrangement

8 de jan. de 2026, 21:09 UTC

Conversa de Mercado

Oil Rises As Trump Said to Back Russia Sanctions Bill -- Market Talk

8 de jan. de 2026, 21:09 UTC

Aquisições, Fusões, Aquisições de Empresas

Rio Tinto Confirms in Talks With Glencore Over Possible Merger

8 de jan. de 2026, 20:21 UTC

Conversa de Mercado

U.S. Natural Gas Futures Down Despite Inventory Draw -- Market Talk

8 de jan. de 2026, 19:44 UTC

Conversa de Mercado

Gold's Shine Masks Deep Drops in Canada Steel, Aluminum Exports -- Market Talk

8 de jan. de 2026, 18:50 UTC

Conversa de Mercado

Mexico's Industrial Production Seen Lower in November -- Market Talk

8 de jan. de 2026, 17:48 UTC

Ganhos

These Stocks Are Moving the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

8 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Auto & Transport Roundup: Market Talk

8 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

8 de jan. de 2026, 17:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

8 de jan. de 2026, 16:45 UTC

Conversa de Mercado

Goldman Lifts 1H LME Copper Forecast -- Market Talk

8 de jan. de 2026, 16:03 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

8 de jan. de 2026, 16:03 UTC

Conversa de Mercado

Currency Markets Could Be Underpricing Medium-Term Risks -- Market Talk

8 de jan. de 2026, 16:02 UTC

Conversa de Mercado

U.S. Natural Gas Inventories Fall As Expected -- Market Talk

8 de jan. de 2026, 15:23 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Defends Its Hostile Bid for Warner -- Update

Comparação entre Pares

Variação de preço

Harmony Biosciences Holdings Inc Previsão

Preço-alvo

By TipRanks

16.72% parte superior

Previsão para 12 meses

Média 43.83 USD 16.72%

Máximo 55 USD

Mínimo 32 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Harmony Biosciences Holdings Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

6 ratings

Comprar

Manter

Vender

Com base em 6 analistas que deram avaliações de ações para Harmony Biosciences Holdings Inc - Dist nos últimos 3 meses.

Pontuação Técnica

By Trading Central

29.8 / N/ASuporte e Resistência

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentimento

By Acuity

111 / 372 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.